Hepatic copper in patients receiving long-term total patenteral nutrition

Journal of Clinical Gastroenterology

Volumn 39, Issue 4, 2005, Pages 318-320

  Blaszyk, Hagen ^a   Wild, Peter J ^b   Oliveira, Andre ^c   Kelly, Darlene G ^c   Burgart, Lawrence J ^c  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF REGENSBURG   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

Biliary transporter; Cholestasis; Liver disease; Steatohepatitis; Trace elements

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BILIRUBIN GLUCURONIDE; COPPER;

ADOLESCENT; ADULT; AGED; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTATIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATIC COPPER OVERLOAD; HISTOPATHOLOGY; HUMAN; LIVER DISEASE; LONG TERM CARE; MALE; PRIORITY JOURNAL; TOTAL PARENTERAL NUTRITION; WILSON DISEASE;

ADOLESCENT; ADULT; AGED; BIOPSY; COPPER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IATROGENIC DISEASE; INTESTINAL DISEASES; LIVER; LIVER DISEASES; MALE; MIDDLE AGED; PARENTERAL NUTRITION, TOTAL; SPECTROPHOTOMETRY, ATOMIC; TIME FACTORS;

EID: 15344348579     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000155135.35315.05     Document Type: Article

References (14)

1. Qureshi WA. Intrahepatic cholestatic syndromes: pathogenesis, clinical features and management. Dig Dis. 1999;17:49-59.
2. Cavicchi M, Beau P, Crenn P, et al. Prevalence of liver disease and contributing factors in patients receiving home patenterai nutrition for permanent intestinal failure. Ann Intern Med. 2000;132:525-532.
3. Kelly DA. Liver complications of pediatric parenteral nutrition: epidemiology. Nutrition. 1998;14:153-157.
4. Moss LR, Amii LA. New approaches to understanding the etiology and treatment of total parenteral nutrition-associated cholestasis. Semin Pediatr Surg. 1999;8:140-147.
5. Ferenci P, Zollner G, Trauner M. Hepatic transport systems. J Gastroenerol Hepatol. 2002;17(suppl):105-112.
6. Spiegel JE, Willenbucher RF. Rapid development of severe copper deficiency in a patient with Crohn's disease receiving parenteral nutrition. JPEN. 1999;23:169-172.
7. Fuhrman MP, Herrmann V, Masidonski P, et al. Pancytopenia after removal of copper from total parenteral nutrition. JPEN. 2000;24:361-366.
8. Papageorgiou T, Zacharoulis D, Xenos D, et al. Determination of trace elements (Cu, Zn, Mn, Pb) and magnesium by atomical absorption in patients receiving total parenteral nutrition. Nutrition. 2002;18:32-34.
9. Pluhator-Murton MM, Fedorak RN, Audette RJ, et al. Trace element contamination of total parenteral nutrition: I. Contribution of component solutions. JPEN. 1999;23:222-227.
10. Pluhator-Murton MM, Fedorak RN, Audette RJ, et al. Extent of trace-element contamination from simulated compounding of total parenteral nutrition solutions. Am J Health Syst Pharm. 1996;53:2299-2303.
11. Phillips JM, Ackerley CA, Superina RA, et al. Excess zinc associated with severe progressive cholestasis in Cree and Ojibwa-Cree children. Lancet. 1996;347:866-868.
12. Danks DM. Copper and liver disease. Eur J Pediatr. 1991;150:142-148.
13. Pluhator-Murton MM, Fedorak RN, Audette RJ, et al. Trace element contamination of total parenteral nutrition. 2. Effect of storage duration and temperature. JPEN. 1999;23:228-232.
14. Pilloni L, Lecca S, VanEyken P, et al. Value of histochemical stains for copper in the diagnosis of Wilson's disease. Histopathology. 1998;33: 28-33.